The impacts of the COVID-19 pandemic on Australia’s myasthenia gravis patients: A self-reported survey study
- 28 December 2024
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (2) , 539-548
Abstract
Introduction/Aims Previous studies have demonstrated high morbidity and mortality in patients with myasthenia gravis (MG) who acquired COVID-19. We aimed to identify the impact of the pandemic on MG disease control, treatment and quality of life. Methods A prospective observational cohort study was conducted to identify the impact of the COVID-19 pandemic on Australian patients with MG. We conducted an online survey through Myasthenia Alliance Australia from May 2022 to July 2022. Results Among the 229 patients who responded to the survey, most patients had three (80; 34.9%) or four (116; 50.7%) doses of the COVID-19 vaccines, 65 (28.4%) had contracted COVID-19, with 6 patients (9.4%) requiring hospitalisation. A large proportion of patients responded that the pandemic had no impact on their MG disease control (123; 53.7%) or treatment (111; 48.5%). Most patients felt the pandemic had either a mild (111; 48.5%) or moderate (50; 21.8%) impact on their mood. Conclusion Our study provides a snapshot of the types of impacts experienced by myasthenic patients during the pandemic, in particular the psychosocial effects. As we continue to live with COVID-19, clinicians should consider its various impacts in the holistic management of their patients.Keywords
This publication has 27 references indexed in Scilit:
- Clinical features, treatments, their impact, and quality of life for Myasthenia Gravis patients in AustraliaJournal of Clinical Neuroscience, 2023
- Outcomes of COVID-19 Infection and Vaccination Among Individuals With Myasthenia GravisJAMA Network Open, 2023
- Prevalence of depression and anxiety among myasthenia gravis (MG) patients: A systematic review and meta‐analysisBrain and Behavior, 2022
- The COVID-19 Pandemic Rages on for People Who Are ImmunocompromisedJAMA, 2022
- Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID‐19Muscle & Nerve, 2022
- Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in IndiaClinical Neurology and Neurosurgery, 2021
- Findings from an online survey on the mental health effects of COVID-19 on Canadians with disabilities and chronic health conditionsDisability and Health Journal, 2021
- COVID-19: The first documented coronavirus pandemic in historyBiomedical Journal, 2020
- Clinical features and impact of myasthenia gravis disease in Australian patientsJournal of Clinical Neuroscience, 2015
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009